2m 2m 2m 2m 2m 2m 2m
COMPASS THERAPTC (CMPX)
NASDAQ
$0.80-$0.02 (-1.90%)
Price as of Oct 22, 2026 7:30 PM EDT- $146.7MMarket Cap
- -80.42%1-Year Change
- BiotechnologyIndustry
COMPASS THERAPTC (CMPX)
$0.80-$0.02 (-1.90%)
CMPX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.81 | ||
Change | -$0.02 (-2.26%) | ||
Open | $0.82 | ||
High | $0.84 | ||
Low | $0.81 | ||
Previous Close | $0.83 | ||
Volume | 1,544,138 | ||
30-Day Average Volume | 6,594,323 | ||
1-Week Change | -7.34% | ||
1-Month Change | -55.25% | ||
1-Year Change | -80.42% | ||
3-Year Change | -58.86% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 180.1M | ||
Total Assets | $190.2M | ||
Market Cap | $146.7M | ||
Enterprise Value | $111.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$25.2M | ||
Free Cash Flow | -$14.9M | ||
EBIT | -$25.2M | ||
EBITDA | -$25.1M | ||
Net Working Capital | $164.8M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -6 | ||
PEG | 0 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue